Highlights Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Market Closed - Hong Kong S.E. Other stock markets 01:38:13 13/06/2024 pm IST			5-day change	1st Jan Change
2.81 ^HKD	+2.55%		-1.06%	-19.02%

12/06	Sino Biopharmaceutical Gets Marketing Go-Ahead for MRI Contrast Agent from Chinese Regulator	MT
12/06	Sino Biopharmaceutical Limited Announces Approval for Marketing of Gadoteridol Injection	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sino Biopharmaceutical Limited Announces Approval for Marketing of Gadoteridol Injection	12/06	CI
Sino Biopharmaceutical's Phase 2 Trial Results of Lung Cancer Tablet Published in Medical Journal	11/06	MT
Sino Biopharmaceutical Limited Announces Publication of Study Findings of Phase II Clinical Trial of KRAS G12C Inhibitor "Garsorasib (D-1553) in the Lancet Respiratory Medicine	11/06	CI
Sino Biopharmaceutical Limited Announces KRAS G12C Inhibitor Garsorasib Tablet (D-1553) Included in the Breakthrough Therapeutic Designation Process	11/06	CI
Final dividend	11/06	FA
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic	06/06	RE
Sino Biopharmaceutical Presents Findings of Anti-Tumor Drug at American Cancer Conference	05/06	MT
Sino Biopharmaceutical's Renal Cancer Combination Treatment Shows Promise in Phase III Trials	24/05	MT
Sino Biopharmaceutical Limited Announces Positive Results on Phase III Study of Benmelstobart Injection in Combination with Anlotinib Hydrochloride Capsules for First-Line Treatment of Advanced Renal Cell Carcinoma	23/05	CI
Sino Biopharmaceutical's Novel Lung Cancer Drug Approved in China; Shares Up 5%	09/05	MT
Sino Biopharmaceutical Limited Receives Marketing Approval from National Medical Products Administration of China	09/05	CI
Sino Biopharmaceutical Limited Announces Approval for Marketing of Category 1 Unecritinib Fumarate Capsules	30/04	CI
Sino Biopharm Completes Phase I Study of Hepatitis B Drug	25/04	MT
Lull in Geopolitical Tensions Lifts Asian Stock Markets	22/04	MT
Hong Kong shares jump 1.5% on policy support; China slips	22/04	RE
Sino Biopharmaceutical Reaches Primary Endpoint for Clinical Research of Myelofibrosis Drug	19/04	MT
Sino Biopharmaceutical Limited Announces Category 1 Innovative Drug Rovadicitinib Obtained Positive Results in Key Clinical Research for Registration	18/04	CI
Sino Biopharm EBT Buys Back HK$12 Million Worth of Shares	17/04	MT
Sino Biopharmaceutical Presents Cancer Drug's Phase-II Clinical Trial Results at AACR 2024	11/04	MT
Sino Biopharmaceutical Trustee Repurchases Shares	08/04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Highlights

Filters